饮食疗法可快速诱导活动期儿童克罗恩病应答与缓解
该研究基于CDED多中心随机试验的73例轻中度活动期儿童克罗恩病患者,比较CDED联合部分肠内营养与全肠内营养的疗效。结果显示第3周时两组多数患者达到快速应答,第3周缓解可提高第6周缓解几率,而依从性差降低第6周缓解几率。
要点
- 饮食疗法(CDED或EEN)可在第3周快速诱导活动期儿童CD临床应答
- 第3周达到缓解者第6周缓解几率更高(OR 6.37)
- 依从性差与第6周缓解几率降低相关
核心结论
- 对活动期儿童克罗恩病,CDED与EEN饮食疗法均可在第3周诱导快速临床应答。
- 识别第3周有无快速应答可能有助于判断依从患者能否在第6周达到临床缓解。
研究设计与样本
- 基于CDED多中心随机试验的数据分析,纳入73例轻中度活动期儿童克罗恩病患者(平均年龄14.2±2.7岁)。
- 患者随机接受全肠内营养(EEN,n=34)或CDED联合50%部分肠内营养(n=39),在基线及第3、6周评估。
- 缓解定义为CD活动指数评分低于10,应答定义为评分下降12.5分或临床缓解,炎症以C反应蛋白评估。
主要发现
- 第3周时CDED组82%、EEN组85%的患者达到饮食快速应答或缓解(DiRe)。
- 血清C反应蛋白中位水平从基线24 mg/L降至第3周5.0 mg/L(P < .001)。
- 第6周达到缓解的49例中,46例(94%)曾出现DiRe,81%在第3周已临床缓解。
- 多因素分析中,第3周缓解增加第6周缓解的比值比(OR 6.37;95%CI 1.6-25;P = .008)。
- 依从性差降低第6周缓解的比值比(OR 0.75;95%CI 0.012-0.46;P = .006)。
临床怎么用
- 对活动期儿童CD可考虑CDED或EEN饮食疗法,并在第3周评估快速应答以辅助预测第6周缓解。
- 应重视饮食疗法依从性,依从性差与第6周缓解几率降低相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Dietary therapies based on exclusion of usual dietary elements induce remission in children with Crohn's disease (CD), whereas re-exposure induces rebound inflammation. We investigated whether a short trial of dietary therapy, to identify patients with and without a rapid response or remission on the diet (DiRe), can be used to predict success or failure of long-term dietary therapy. METHODS: We collected data from the multicenter randomized trial of the CD exclusion diet (CDED). We analyzed data from 73 children with mild to moderate CD (mean age, 14.2 ± 2.7 y) randomly assigned to groups given either exclusive enteral nutrition (EEN, n = 34) or the CDED with 50% (partial) enteral nutrition (n = 39). Patients were examined at baseline and at weeks 3 and 6 of the diet. Remission was defined as CD activity index scores below 10 and response was defined as a decrease in score of 12.5 points or clinical remission. Inflammation was assessed by measurement of C-reactive protein. RESULTS: At week 3 of the diet, 82% of patients in the CDED group and 85% of patients in the EEN group had a DiRe. Median serum levels of C-reactive protein had decreased from 24 mg/L at baseline to 5.0 mg/L at week 3 (P < .001). Among the 49 patients in remission at week 6, 46 patients (94%) had a DiRe and 81% were in clinical remission by week 3. In multivariable analysis, remission at week 3 increased odds of remission by week 6 (odds ratio, 6.37; 95% CI, 1.6-25; P = .008) whereas poor compliance reduced odds of remission at week 6 (odds ratio, 0.75; 95% CI, 0.012-0.46; P = .006). CONCLUSIONS: For pediatric patients with active CD, dietary therapies (CDED and EEN) induce a rapid clinical response (by week 3). Identification of patients with and without a rapid response to diet might help identify those who, with compliance, will be in clinical remission by week 6 of the diet. ClinicalTrials.gov no: NCT01728870.
引用
- Sigall Boneh R, Van Limbergen J, Wine E, et al. Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn's Disease. Clin Gastroenterol Hepatol. 2020. PMID: 32302709. doi:10.1016/j.cgh.2020.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。